News | January 28, 2015

Cherenkov Emissions Provide Dartmouth Investigators Real-Time Tool for Quality Assurance in Radiation Therapy

Cherenkov light can be imaged and used to confirm that complex spatial dose distribution imparted in dynamic treatment plans is delivered correctly

January 28, 2015 — Using a camera and water tank, investigators from Dartmouth-Hitchcock’s Norris Cotton Cancer Center, led by Brian Pogue, Ph.D., and David J. Gladstone, ScD, demonstrated that induced Cherenkov light can be imaged and used to confirm that the complex spatial dose distribution imparted in dynamic treatment plans is being delivered correctly. The paper “Video-rate optical dosimetry and dynamic visualization of IMRT and VMAT treatment plans in water using Cherenkov radiation,” was published in Medical Physics.

Cherenkov radiation is emitted and exists as a ‘free’ optical signal that has not been previously utilized,” explained Adam Glaser, lead Ph.D. student on the project. “By imaging the light, we can improve the quality and accuracy of delivered plans to prevent radiation mistakes. This will ultimately improve the overall outcome for patients being treated.”

The Cherenkov Effect is responsible for the characteristic blue glow of nuclear reactors. Although the phenomenon has been constructively utilized for decades in high-energy particle physics and astrophysics, only recently has there been investigation into its utility in radiation therapy. In that context, it is the only current method that can reveal dosimetric information while remaining completely non-invasive. Essentially, the signal comes directly from the water phantom being irradiated rather than introducing detector arrays.

To accomplish this work, a high-sensitivity, intensified CCD camera was set up to take a two-dimensional projected image during delivery of the Intensity-Modulated Radiation Therapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT) plans. The camera focused on a water bath, and was gated to the Linear Accelerator to take a rapid series of photos that were connected to make an ersatz video and used to compare overall light distribution with the original dosing plan.

“Compared to conventional [quality assurance] methods, the advantages of this technique are video-rate, real-time data acquisition, two dimensional projection of 3-D dose distribution, and high spatial resolution that is limited only by the collection optics of the system,” said David J. Gladstone, ScD.

Next steps for the team at Norris Cotton Cancer Center are to extend the system to tomographic 3-D data recovery, as well as continuing clinical trials to investigate Cherenkov light imaged directly from a patient’s tissue surface.

For more information: www.cancer.dartmouth.edu

 

 

Related Content

Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares
RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital
News | Treatment Planning | January 30, 2018
Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for...
Small-Cell Lung Cancer Patients Face Barriers to Standard-of-Care Treatment
News | Lung Cancer | January 29, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the...
Overlay Init